Family Planning Knowledge, Attitudes, and Practices of Postpartum Malawian Women
|ClinicalTrials.gov Identifier: NCT01893021|
Recruitment Status : Completed
First Posted : July 8, 2013
Last Update Posted : February 4, 2015
The purpose of this study is to understand the family planning needs and practices of postpartum Malawian women, with a focus on long-acting reversible contraception (LARC).
- Postpartum women who are older, who have a history of unintended pregnancy, who do not desire another child within 2 years, and who were counseled about LARC during their pregnancy are more likely to have interest in using LARC.
- Postpartum women who are older are more likely to be aware of LARC methods.
- HIV+ postpartum Malawian women will have similar knowledge about LARC as postpartum Malawian women who are HIV-.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||634 participants|
|Official Title:||Family Planning Knowledge, Attitudes, and Practices of HIV+ and HIV- Postpartum Malawian Women|
|Study Start Date :||May 2013|
|Actual Primary Completion Date :||October 2014|
|Actual Study Completion Date :||October 2014|
|Postpartum Malawian women|
- Knowledge about the intrauterine device (IUD) and contraceptive implant [ Time Frame: Upon enrollment ]A 14-question test about the IUD and implant will be administered to all study participants upon enrollment.
- Proportion of women using intrauterine device (IUD) and contraceptive implant [ Time Frame: 3, 6, and 12 months postpartum ]We will compare the proportions of HIV+ and HIV- women who are using the IUD and implant at 3, 6, and 12 months postpartum.
- Barriers to receiving intrauterine device (IUD) and contraceptive implant [ Time Frame: Up to 12 months postpartum ]Descriptive statistics will be used to analyze the reasons given for not receiving the IUD or implant at 3, 5, and 12 months postpartum if a woman had wanted to use it.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01893021
|Bwaila Maternity Hospital|
|Principal Investigator:||Jennifer Tang, MD, MSCR||University of North Carolina, Chapel Hill|
|Study Director:||Mina Hosseinipour, MD, MPH||University of North Carolina, Chapel Hill|